Cramer’s Scientific Instrument Purchase for Tomorrow Morning

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Tonight Cramer said tonight on his MAD MONEY show on CNBC there is no reason to wait for the J.P.Morgan Biotech conference, because he already has the stocks to play.

Thermo Fisher (TMO) presents at 11:00 AM EST tomorrow, and Cramer said he would buy it around 10AM ahead of its prsentation.  They are the one-stop shop for all the scientific instrument and analytic needs now.  Itrecently merged with Fisher Scientific and has over 350,000 customers in over 150 countries.  After tomorrow Cramer thinks you’ll see waves of analyst coverage coming into the stock.  This has the arms dealer model where it sells instruments and equipment to everyone in the field and it has a small group of analysts that cover it.  He likes its ability cut costs and likes its pricing power.  He thinks they have also been conservative in guidance.  He thinks that they could have quarterly upside for a while.

Prior to TMO, Cramer picked Gilead (GILD) as one to buy into the conference.  Here is the full commentary on Gilead from Cramer.

In a call in Cramer panned Ligand Pharma (LGND) and said he wasn’t worried about a small portion of insider ownership in Genentech (DNA) and Amgen (AMGN) because they are so huge.

Jon C. Ogg
January 8, 2007

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618